We are in the process of changing our name to Health Innovation North East North Cumbria (HI NENC), in the interim you will see references to both AHSN NENC and HI NENC

Transfer Of Value Disclosure

FINANCIAL INFORMATION:

The following describes the funding received from non-NHS organisations to support programmes of work that aim to improve the health and care system in  the North East and North Cumbria:

Organisations Involved Start Date End Date Monetary Value Reason for Benefit
Chiesi Farmaceutici and AHSN NENC 01/02/2022 16/05/2022 £5,000.00 To develop the Pharm outcomes template for the Tees Valley Inhaler Project
OrionPharma (UK) Ltd and AHSN NENC 01/02/2022 16/05/2022 £5,400.00 To develop the Pharm outcomes template for the Tees Valley Inhaler Project
AstraZeneca PLC and AHSN NENC 01/02/2022 16/05/2022 £26,400.00 To deliver the pilot programme of work for the Tees Valley Inhaler project
GlaxoSmithKline and AHSN NENC 01/02/2022 16/05/2022 £5,400.00 To develop the Pharm outcomes template as part of the Tees Valley Inhaler project
Sanofi 31/03/2022 30/09/2023 £37,479.28 JWA to facilitate earlier diagnosis of Fabry, Pompe and Gaucher diseases through the use of disease prediction models using real-work data from Primary Care records (CDRC – rare diseases)
Sanofi 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Amgen Ltd 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Novartis Pharmaceuticals UK Ltd 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Daiichi Sankyo 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Amarin UK Ltd 20/10/2022 20/10/2022 £400.00 Sponsorship to part fund the Northern Lipids Forum Event held on the 20th October 2022
Sanofi (registered name Aventis Pharma Ltd) 18/11/2022 31/03/2023 £768.00 Reimbursement costs for a guest speaker at a Sanofi event
Novartis Pharmaceuticals 23/12/2022 23/12/2023 £150,000 Undertake medical education activities around holistic lipid management and prevention of CVD
Boehringer Ingleheim 01/02/2022 30/09/2023 3000 Contracts Grant/donation towards education and service development in support of Improving outcomes for Respiratory patients, Tees Valley inhaler project
Novartis Pharmaceuticals UK Limited 20/10/2021 31/03/2024 £111,294 Support the implementation of the NHSE-Novartis collaboration project as part of the AHSN Network’s national lipid optimisation programme
Novartis Pharmaceuticals UK Limited 01/04/2023 31/03/2024 £198,000 Sustain secondary care and primary care clinical roles, develop primary care lipid hub and embed projects supported by AHSN NENC CVD team
Novartis Pharmaceuticals UK Limited 27/09/2022 26/04/2024 £135,024 Promote the use of the nationally endorsed lipid management pathway and service transformation work and promote adoption of best practice
Amarin UK Limited 17/07/2023 19/10/2023 £650 Northern Lipid Forum